Atrioventricular block secondary to transient causes and long‐term recurrence after an index event
JG Santos, M Martinho, B Ferreira… - Pacing and Clinical …, 2024 - Wiley Online Library
Background Atrioventricular block (AVB) secondary to transient causes can recover with its
correction. However, studies assessing predictors of recovery and long‐term recurrence are …
correction. However, studies assessing predictors of recovery and long‐term recurrence are …
Beta-Blocker-Related Atrioventricular Conduction Disorders—A Single Tertiary Referral Center Experience
Background and Objectives: Drug-related bradyarrhythmia is a well-documented major
adverse event among beta-blocker users and a potential cause for hospitalization or …
adverse event among beta-blocker users and a potential cause for hospitalization or …
Bloqueo auriculoventricular de tercer grado: caso clínico
F Loaiza, M Morgado, X Yambay - Religación: Revista de …, 2024 - dialnet.unirioja.es
El bloqueo auriculoventricular (BAV) es un trastorno eléctrico cardíaco caracterizado por
una conducción alterada de las aurículas a los ventrículos. Este artículo tiene por objetivo …
una conducción alterada de las aurículas a los ventrículos. Este artículo tiene por objetivo …
Systemic immune‐inflammation index as a tool for predicting the need for a permanent pacemaker in patients with drug‐induced atrioventricular block
O Şenöz, A Erseçgin - Pacing and Clinical Electrophysiology, 2021 - Wiley Online Library
Background Drug‐induced atrioventricular block (AVB) is generally considered reversible
and does not require a permanent pacemaker implantation (PPM). However, some studies …
and does not require a permanent pacemaker implantation (PPM). However, some studies …
Clinical significance and management of atrioventricular block associated with bradycardic/antiarrhythmic drug therapy: Drug-induced or drug-revealed?
D Sfairopoulos, G Bazoukis, S Sideris, N Fragakis… - 2024 - authorea.com
The development of advanced atrioventricular block (AVB) in patients on bradycardic and/or
antiarrhythmic therapy (drug-related AVB) represents a clinical challenge, raising the …
antiarrhythmic therapy (drug-related AVB) represents a clinical challenge, raising the …
[PDF][PDF] Myringosclerosis as a predictor of the requirement for a permanent pacemaker in patients with drug-related atrioventricular block
MS Cosgun, H Hamur, H Degirmenci… - Biomedical …, 2022 - biomed.papers.upol.cz
Aims. Drug-related atrioventricular block (DR-AVB) may develop in patients with underlying
latent degenerative conduction disorders, especially with antiarrhythmics and …
latent degenerative conduction disorders, especially with antiarrhythmics and …
Seguridad y Efectividad del sistema de sujeción de Marcapasos Temporales de Fijación Activa–KronoSafe®
R Vicente Miralles - 2023 - dspace.umh.es
El objetivo del presente estudio es analizar la seguridad y la efectividad del nuevo sistema
de sujeción de marcapasos temporales de fijación activa (KronoSafe®), utilizando …
de sujeción de marcapasos temporales de fijación activa (KronoSafe®), utilizando …
[引用][C] Valor predictivo de la respuesta a la atropina en pacientes con bradiarritmia en presencia de fármacos bradicardizantes
L Álvarez-Acosta, L Anmad Shihadeh… - Rev. esp. cardiol …, 2022 - pesquisa.bvsalud.org
Valor predictivo de la respuesta a la atropina en pacientes con bradiarritmia en presencia de
fármacos bradicardizantes | Rev. esp. cardiol. (Ed. impr.);75(11): 969-971, nov. 2022. tab …
fármacos bradicardizantes | Rev. esp. cardiol. (Ed. impr.);75(11): 969-971, nov. 2022. tab …
[引用][C] Predictive value of atropine response in patients with bradyarrhythmia in the presence of bradycardic drugs.
L Álvarez-Acosta, LI Pérez-Méndez… - Revista Espanola de …, 2022 - europepmc.org
Predictive value of atropine response in patients with bradyarrhythmia in the presence of
bradycardic drugs. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
bradycardic drugs. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …